267 related articles for article (PubMed ID: 19089931)
1. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
Morrison DA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
[No Abstract] [Full Text] [Related]
2. Stenting unprotected left main: the outcome is not always favorable.
Colombo A
Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
[No Abstract] [Full Text] [Related]
3. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
Bailey SR
Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
[No Abstract] [Full Text] [Related]
4. Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
Hillegass WB
Catheter Cardiovasc Interv; 2010 Jul; 76(1):58-9. PubMed ID: 20578193
[No Abstract] [Full Text] [Related]
5. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
Wood FO; Saylors EK; Schneider JE; Jobe RL; Mann JT
Catheter Cardiovasc Interv; 2008 Mar; 71(4):533-8. PubMed ID: 18307224
[TBL] [Abstract][Full Text] [Related]
6. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
[TBL] [Abstract][Full Text] [Related]
7. Off-label use and the spectre of drug-eluting stent thrombosis.
Cook S; Wenaweser P
Circ Cardiovasc Interv; 2009 Aug; 2(4):273-6. PubMed ID: 20031728
[No Abstract] [Full Text] [Related]
8. Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes.
Moliterno DJ
Catheter Cardiovasc Interv; 2009 Jan; 73(1):32-3. PubMed ID: 19089933
[No Abstract] [Full Text] [Related]
9. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results.
Sheiban I; Ballari GP; Moretti C; Marra WG; Meliga E; Omedè P; Sciuto F; Trevi GP
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):582-8. PubMed ID: 17667028
[TBL] [Abstract][Full Text] [Related]
11. Inflation time and drug-eluting stent: the longer, the better..
Bertrand OF
Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881
[No Abstract] [Full Text] [Related]
12. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
Hillegass W
Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
[No Abstract] [Full Text] [Related]
13. What kind of stent for you today and how would you like it prepared?
Butman SM
Catheter Cardiovasc Interv; 2007 Aug; 70(2):173-4. PubMed ID: 17630654
[No Abstract] [Full Text] [Related]
14. SES for AMI: moving in the right direction.
Vetrovec GW
Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
[No Abstract] [Full Text] [Related]
15. Long-term follow-up of the First In Man experience with everolimus-eluting stents.
Kimmelstiel C
Catheter Cardiovasc Interv; 2010 Jun; 75(7):1004-5. PubMed ID: 20517960
[No Abstract] [Full Text] [Related]
16. Are we totally clear?
Morrison DA
Catheter Cardiovasc Interv; 2009 Dec; 74(7):987-8. PubMed ID: 19953511
[No Abstract] [Full Text] [Related]
17. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
18. Multivessel disease in diabetics: does DES level the field?
Hillegass W
Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
[No Abstract] [Full Text] [Related]
19. Another small step for small vessels.
Morrison DA
Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
[No Abstract] [Full Text] [Related]
20. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Leesar MA
Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
